COVID-19: Comments on the NIH’s Remdesivir trial

Vinay Prasad has some insightful commentary on the NIH’s remdesivir trial (which was finally published in NEJM yesterday):


[1] Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — Preliminary Report. New England Journal of Medicine. May 2020. doi:10.1056/nejmoa2007764